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Renal Vasodilatory Effect of Endothelial Stimulation in Patients With
Chronic Congestive Heart Failure co.05 vs. baseline). Acetykbolbte also caused a signikant mduction in renal vascnlar resistance (maximal reduction 55 + 6%) and iucreasebtrenalbloodRow(~lincreasel3fi+: §4%).fn contrast, nitmglycertn admbdstration showed no signilicunt e&t on tenalvascular&smnceandbloodtlow.
Concfusions. Stimulation of endotbeliumderived nittic oxide witb acetylcboline results ht a significant vasodilatory effect on both conductance and resistance renal blood vessels and leads to a marked reduction in renal vascular resistance and enhancement of renal blood flow. Nitroglycerin, an exogenous nitric oxide donor, caused a selective vasodilatoty effect on xual conductance but not on resistance blood vessels and failed to increase renal blood flow. These data suggest the possibility that stimulation of endogenous nitric oxide production in the kidney could be used as a therapeutic target for enhancement of renal flow in patients with heart failure.
( O&cfives. This study sought to examine the vasodilatory response of the renal circulation to endothelial stimulation in patients witb cbronk beurt failure Bac&u&.
Renal blood flow is often reduced in patients with chronic congestive beatt failure and may lead to deterioration of remI function. Stimulathm of renal endothelbnu has been shown to cause renal vasodilatioo in animals and in isolated human renal artery. The vasoregulatory role of the renal endothelium in patints with heart failnre has not been evahmted.
i%fefkd. Renal vasmlUat01~ elka ofendothelial sthmdation with acetylcholhtewusassesxdandcomparedwiththatofendothelialiudepedentvclsodilationwlth~~Bothdrogswereinfusod intothemahttenalartery.Renalartetycross-sectionalareawus measwed witb intmvascular tdtraso~d and renal blood Row vehxity with the aid of aa intravaswlar Doppler technique
Renal blood flow is often reduced in patients with chronic heart failure (1,2) and may lead to an impairment of renal function. Changes in renal blood flow have been commonly attributed to central hemodynamic derangement (3) . Although both cardiac output and regional renal blood flow are often reduced in patients with congestive heart failure, the correlation between these two variables in individual patients has been poor (4). In addition, enhancement of cardiac output with cardiotonic or vasoactive drugs often results in only a small or no effect on renal blood flow (1, (5) (6) (7) . These findings may indicate the importance of local mechanisms for vasoregulation of the renal circulation in patients with congestive heart failure. Understanding of such mechanisms may be helpful in the design of new therapeutic strategies for improvement of renal function in patients with heart failure. The role' of the endothelium as a potent regulator of vascular smooth muscle relaxation in various circulatory systems has been clearly established in the past several years (&9).
Recent animal studies have also demonstrated that activation of the endothelial L-arginine pathway in isolated kidneys as well as in vivo studies can lead to a decrease in renal vascular resistance (IO) and an increase in renal blood flow, diuresis and natriuresis (11-16). In addition, endothelial ,stimulation has been reported to cause relaxation in isolated human renal arteries (17) . Although these studies support the vasoregulatory role of the renal endothelium, the in vivo effect of endothelial stimulation on the renal circulation in humans has not been studied. In addition, several investigations have demonstrated a significant attenuation of endothelial reaction to stimulatory effects in patients with congestive heart failure, resulting in impairment of vasodilatory response (l&19). The purpose of the present study was, therefore, to evaluate the vasodilatoty response of the renal circulation to endothelial stimulation in patients with chronic congestive heart failure.
Methods
Patients.
Twelve male patients in clinically stabie condition with a history of moderately severe or severe chronic conges- tive heart failure who underwent diagnostic cardiac catheterization were included in the study (mean age 44 -C 4 years, range 26 to 64). The etiology of heart failure was coronary artery disease in four patients and unknown in eight. All patients had severe depression of left ventricular systolic function as documented by contrast or radionuclide ventriculography or by echocardiography (three patients). Left ventricular ejection fraction as determined in nine patients ranged from 14% to 32% (mean 24 -C 2%). Mean hemodynamic values as measure3 during cardiac catheterization were as follows: heart rate 86 2 5 beats/min, mean blood pressure 92 + 4 mm Hg, mean right atrial pressure 8 * 1 mm Hg, mean pulmonary artery pressure 31 t 3 mm Hg, mean pulmonary artery wedge pressure 20 + 2 mm Hg, cardiac index 3.3 +-0.2 liters/min per m', stroke volume index 39 + 4 ml/min per m* and systemic vascular resistance 1,158 x 721 dynesscm-'. All patients signed a consent form approved by the research committee of the Los Angeles County/University of Southern California Medical Center.
Study pmtoeol. Organic nitrates (six patients) were discontinued at least 24 h before the study to prevent attenuation of nitroglycerin effect during the study due to nitrate tolerance (18) ; other medications (diuretic drugs in all patients, digoxin in 11 and angiotensin-converting enzyme inhibitors in 10) were withheld on the day of the study. Premeditation before cardiac catheterization included intravenous metoclopramide (10 mg) and benadryl(50 mg). During cardiac catheterization and the study, patients received 1.0 to 2.0 mg of intravenous midazolam hyrochloride for sedation. Nitroglycerin, either sublingual, intravenous or intracoronary, was not allowed during cardiac catheterization and until the end of the study. After completion of diagnostic cardiac catheterization, a triple-lumen SwanGanz catheter used for the performance of right heart catheterization was withdrawn from the pulmonary artery and positioned in the midportion of either the: right or left renal vein. In cases where engagement of the Swan-Ganz catheter into the renal vein was unsuccessful, a 7F diagnostic Judkins right or left coronary artery catheter was used. An 8F angioplasty multipurpose or a Judkins right coronary artery guiding catheter was then placed in the ipsilateral renal artery with the tip positioned in the proximal or midportion of the main artery (Fig. I ). Catheter position both in the renal vein and artery was confirmed with a small amount (-5 ml) of angiographic contrast medium (Hexibrix, Mallinkrodt Medical). A 0.018-in. (0.045 cm) Doppler guide wire (Flowire, Cardiometrics, Inc.) was then introduced into the guiding catheter through a valved sidearm connector, and its tip was positioned under direct visualization in the main renal artery and maintained in a parallel position to flow. A commercially available 3.5F or 4.3F intravascular ultrasound catheter (Mansfield, Boston Scientific Corporation) was then placed through the guiding catheter and was positioned under fluoroscopic guidance next to the Doppler wire (Fig. 1 ). Images were obtained with a commercially available intracoronary ultrasound imaging system (Sono Intravascular, Hewlett-Packard) at 30 frames/s and recorded on 0.5-in. high quality super VHS videotape for subsequent off-line analysis. Renal artery lumen planimetry was later performed from the taped images, and cross-sectional area was determined with specially designed software. The spectral Doppler renal blood Row velocities were recorded. The timevelocity integral was measured as the area under the outermost portion of the spectral velocity envelope. To correct for changes related to respiration and cardiac cycle, 15 to 30 beats were used for measurements of both renal artery crosssectional area and Doppler velocity time integral, and average values are reported. Renal blood flow (in mUmin) was calculated as the prodlrct of the cross-sectional area of the renal artery and the velocity time integral using the following formula: Row = Heart rate per minute x Velocity-time integral x Cross-sectional area. Renal blood Row index was calculated for each patient by dividing renal blood flow by body surface area. Renal vascular resistance was calculated as follows: 80 (Mean renal artery blood pressure -Mean renal vein pressure) Renal blood flow.
Renal venous and arterial pressures were measured directly with the aid of the venous and arterial catheters, fluid-tilled pressure tubings and standard transducers. Infusion of drugs was done through the arterial catheter diiectly into the renal artery.
Drugs. Acetylcholine (Miochol, lolab Pharmaceuticals) was mixed in 5% dextrose in water to achieve a blood concentration of IO-', lo-' and lo-" mobliter, assuming an CSA = main renal artery crossseek& area; HR = heart rate; RAP = mean renal artery blood pressure; RBF = renal bled flow: RVP = mean renal vein presssure; RVR = renal vascular resistance: WI = velocity-time integral.
average renal blood flow in patients with chronic heart failure of 600 ml/min (4-6). Nitroglycerin (Baxter Healthcare Corporation) was infused at a rate calculated to achieve blood concentrations of lo-', 10e6 and lo-' mohliter. Both drugs were drawn from hospital formuiary stacks and prepared <60 min before their use. The drugs were infused at a rate of 2 ml/mitt controlled by a volumetric pump for approximately 3 to 5 min for each concentration into the renal artery. Similar concentrations of both acetyicholine and nitroglycerin were used in previous studies evaluating endotheiiai function of coronary and peripheral arterial circulation (19, 20) .
istration of acetylcholine and 0.35 t 0.03 cm* before nitrogiycerin (Table 1) ; the difference was not statistically significant. Both acetylchoiine and nitroglycerin resuhcd in a dosedependent, small but statistically significant, increase in renal artery cross-sectional arra ( Fig. 2 and 3 ). Maximal increase in this variable was 14 t 5% for acetylchoiine and 15 2 5% for nitmzlycerin. The difference between these two interventions was not statistically significant.
Dasehne hemodynamic variables, intravascular ultrasound and Doppler flow velocity were measured after 3 to 5 min of intraarterial infusion of 5% dextrose in water. After baseline measurements, patients were randomized to receive either acetylchoiine (six patients) or nitroglycerin infusion (six patients) as the first drug. Hemodynamic measurements and intravascular uitrasound and Doppler flow velocity recordings were repeated during the last minute of infusion of each drug concentration. Ten to 15 minutes was then allowed for washout of the first drug and was followed by a second baseline measurement and the administration of the second drug using the identical protocol.
Velocity-time inregml. There was no significant difference between baseline values of the velocity-time integral before administration of both drugs (22 -C 3 vs. 24 _' 3 cm). A significant and dose-dependent increase in velocity-time integral was found during acetyichoiine infusion (Table 1, Fig. 3 ). The velocity-time integral increased 61 I! 10% during infusion of lo-* mot/liter acetylcholine (p < 0.01 vs. baseline) and continued to increase during lo-' and 10m6 mot/liter (99 +-15% and 120 + 18%, p < 0.05 vs. lo-* mot/liter for both). In contrast, the effect of nitroglycerin on thevelocity-time integral was small (Table 1 , Fig. 4 ) and did no+ ac:.ieve statistical significance.
Rend blood flow. As shown in Table 1 , there was no significant difference between baseline values of renal blood Data analysis. An analysis of variance for repeated measurements was used to determine a statistical difference between the absolute values as well as percent differences from baseline. In case of a difference, the Newman-Keuls test was applied. Data were analyzed for the entire group of 12 patients. To detect any carry over effect related to the crossover design of the study (21), the same analysis was performed for the two subgroups of six patients who received either acetyicholme or nitrogtycerin as their first drug., AU results are expressed as mean value + SE, a p value ~0.05 was considered statistically significant. . A significant and dose-related increase in cakulated renal blood flow was found during acetylcholine infusion (Fig. 5) . Rena1 blood flow increased 67 2 12% during 10V8 mobliter acetylcholine (p < 0.05 vs. baseline), 122 2 17% during 10e7 mohliter acetykholine and 145 It 1% during 10e6 mol/liter acetykholii (both p < 0.05 vs. 10e8 mol/hter). In contrast to the signihcant effect of acetykholme on renal blood Raw, intraarterial infusion of nitroglycerin at all three doses (Fig. 5 ) demonstrated ouly a small and ?&tically insigniticant change in renal blood flow (13 ? 6%,16 ? 8% and 16 + 6%, nqectively).
Heart rate WK.I bioodpmwes. No significant changes were noted in values of heart rate and renal arterial and venous blood pressures during the intrarenal infusion of both acetylcholine and nitroglycerin (Table 1) . Renal dynesscn-' for acetylcholine, tO,?i5 z 931 dynesscm's for nitroglycerin) ( Table 1 ) during acetylcholine infusion. Renal vascular resistance was reduced 39 t 5% during 10-s mohliter acetylcholine, 52 2 7% during 10e7 mohliter acetylcholine and 55 + 6% during IO-" mohliter acetykholine (all p < 0.05 vs. baseline) (Fig 6) . In contrast inrrarenal infusii of graded doses of nitroglycerin resulted in a small but statistically insignifkant decrease (6 t 6%,4 -t 10% and !2 + 6%: respectively). Heart rate showed no significant change during the infusion of both drugs at all concentrations (Tables 2 and 3) . Mean renal arterial blood pressure showed a small but statistically significant decline during administration of nitroglycerin at concentrations of lo-' mohliter and remained unchanged during acx#choline administration. Both drugs resulted in a dose-rehted increase in mean renal artery cross-sectiona! area. Although increase in absolute values of cross-sectional area did not reach statistical significance during acetylcholine administration, a maximal increase in this variable was similar for both drugs (20 5 10% for 10W6 mol/liter acetylcholine, 19 t 10% for lo-' mot/liter nitroglycerin, p = NS). Renal vascular resistance demonstrated a significant decrease during acetylcholine administration that was associated with a marked and statistically significant increase in Doppler velocity-time integral and calculated renal blood flow. In contrast, these three variables showed no significant change during nitroglycerin infusion.
Discussion
The present study provides to the best of our knowledge a first evaluation of the renal circulatory response to endothelial stimu!atioo in patients with chronic congestive heart failure. The results of the study demonstrate a marked vasodilatory effect of acetylcholine, resulting in a significant increase in cross-sectional area of the main renal artery and a substantial reduction in renal vascular resistance, accompanied by a marked augmentation of renal blood flow. These hndings support previously pubiiihed reports demonstrating acetylcholine-mediated renal vasodilatoty effects in vitro and in viva animal experimentatiors (lo-1622-Z) and in isolated human renal artery (17) .
The vasodilatory effect of acetylcholine on the renal circulation is likely to be mediated by endothelial stimulation of endogenous nitric oxide production. This mechanism is sup ported by a similar relaxing effect of acetylcholine on human and animal renal arteries with but not in those without endothehum (1726) and previously reported inhibition of renal hemodynamic effects of acetylcholine with No-monomethyl-L-arginiie, a specific nitric oxide inhibitor, in animal experimentations (23,24,272@. EndotheIialderived nitric oxide stimulates the enzyme guanylate q&se, which leads to accumulation of cyclic guanosine monophosphate in the vascular smooth muscle, which results in vasorelaxation (30) . Tolins et al. (29) evaluated the role of nitric oxide in regulation of renal hemodynamic responses in the anesthetized rat in vivo and demonstrated a dose-related relation between the hemcdynamic effect of acetylcholiie and rates of cyclic guanosine monophosphate excretion, providing further evidence for acetykholine-induced endothelial-derived nitric oxide synthesis as the mechanism of renal vasodilation. Table t Nitroglycerin is an organic nitrate with potent vasodilatory activity. The therapeutic effect of this drug occurs after intracellular conversion to nitric oxide, which activates the enzyme guanylate cyclase, which leads to the production of cyclic guanosine monophosphate and vaso&tation (29) (30) (31) (32) . Despite the shared properties of et&helium-derived nitric oxide and organic nitrates, the effects of acetykholine and nitroglycerin on the renal circu!ation were diEertnt in the present study. Whereas the i&renal administration of nitroglycerin resulted in a sekctive vasodilatory effect on the main renal artery, it had only little and statistically insignificant effect on renal vascular resistance and renal blood flow, indicating a selective effect on large conductance vessels but lack of effect on small resistance blood vessels in the kidney. In contrast, acetylcholine increased main renal artery cross-sectional area, combined with a substantial effect on renal vascular resistance and renal blood flow, demonstrating its vasodilatory efiect on both large conductance and smail resistance renal blood vessels. The effect of acetjlcholine on resistance blood vessels in the kidney has also been reported (33) in animal studies that showed a vasodilatory effect of acetylcholine on renal interlobular arteries as well as on tierent and efferent glornerular microvessels.
The reason for the difference in the effect of acetylcholme, a stimulator of endogenous nitric oxide production, and nitroglycerin, an exogenous nitric oxide donor, is not clear. However, failure of systemic administration of nitroglycerin to augment renal blood flow measured by other methods has previously been demonstrated in both animals and humans with heart failure (1, 5, 33) . In addition, a similar selective effect of nitroglycerin was demonstrated by Selke et al. (34) , who showed a potent dilation of large, but only minimal effects on small, coronary microvesz&. Lack of available sulfhydryl groups was suggested as the cause for the heterogenous re+onse of coronary microvascular response to nitroglyczrin (35) .
Several investigators have reported impaired endotheliumdependent vasodilator function in patients with heart failure (l&20,36). Assessment of the coronary as well as the peripheral c&culatory response to acetylcholine administrqtion was shown to be diminished. The results of the present study clearly indicate a strong endothelial response in the renal circulation in patients with chronic heart failure and should provide a basis for further evaluation of the therapeutic impliitions of renal endothelial stimulation for improvement of renal function in patients with chronic congestive heart failure.
Study limitations. The present study was conducted in a randomized, crmer manner. Because of patient considerations, a washout period in between infusion of the t-wo study drugs was limited to 10 to 15 min. Although a similar washout period has been used in previous studies (21), a carryaer effect with at least partial persistence of the therapeutic effect of the first drug during the administration of the second can't be ruled out ( fig. 3 and 4) . For this reason, an additiona; analysis of the effect of each of the study drugs in six of the patients who received it 61% was performed The results of this analysis demonstrated similar results to those obtained in all 12 patients aad confirmed the validity of the study findings. In addition, all patients in the present study were treated with standard heart failure therapy, which could have affected endoWial function.
Sumaey. Our study demonstrates a strong renal vasodilatory effect of acetylcholii, which results in a substantial decrease in renai vasc&r resistaoce and augmentation of renal blood flow. This effect is liiely to be due to the stimulate-y effect of acetylcholine on endothelial prod&on of endogenous nitric oxide. Intrarenal administratioil of nitroglycerin, an exogenous nitric oxide donor, could not reproduce the acetykholine effect. This drug caused a similar dilation of the main renal artery but failed to significantly a&t either renal vascular resistance or renal blood fiow. These findings indite a selective vasodiiatory effect of nitroglycerin, an exogenous nitric oxide donor, on renal conductance but not on resistance blood vessels. In contrast, stimulation of endotheliurn-derived nitric oxide with aa%ylcholine results in a significant vasodilation of both conductance and resistance vessels. The results of the present study therefore raise ['he possibility of renal endothelial stimulation and endogenous nitric oxide productian as a potential therapeutic target for enhancement of renal flow in patients with chronic congestive heart failure.
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